Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $150 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Michael Cooney, PhD

Michael Cooney, PhD

Associate
Life Sciences
Boston

Experience

Dr. Cooney joined Bain Capital Life Sciences in 2021 as an associate. He was previously a Bain Capital Life Sciences fellow.  

Prior to joining Bain Capital, Dr. Cooney was a graduate student researcher in the Department of Genetics at Harvard Medical School, where he studied the roles of genomic instability and epigenetic dysfunction in aging. Before this he worked at Genocea Biosciences, performing pre-clinical and clinical research on T-cell-inducing vaccines for infectious diseases.    
 


Education

Dr. Cooney received his PhD in Biological and Biomedical Sciences from Harvard University. He graduated from Tufts University with a BS in Biology and a BS in Biotechnology.